AstraZeneca COVID-19 Vaccine Data Shows Promising Signs In Older Age Group: FT
Data from AstraZeneca plc's (NASDAQ: AZN) COVID-19 vaccine trial, developed in collaboration with the University of Oxford, has shown encouraging signs for the elderly, the
